Kazia Therapeutics Limited. Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019
Kazia Therapeutics Limited. (KZIA) had Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 of $7.50 per share as of 2025-01-14, per its 20-F filed 2025-11-07.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019 · last filed 2025-11-07
- 2025-01-14: Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 $7.50.
- 2024-05-17: Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 $13.50.
- 2023-11-30: Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 $29.15; Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 as first filed $0.58.
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Other Equity Instruments Exercisable In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2025-01-14 | $7.50 20-F · filed 2025-11-07 | |
| 2024-05-17 | $13.50 20-F · filed 2025-11-07 | |
| 2023-11-30 | $29.15 20-F · filed 2025-11-07 | $0.58 6-K · filed 2024-03-27 |